70 News & Press Releases found
Agilent Technologies, Inc. News
-
Agilent Technologies Presents Thought Leader Award to Human Microbiome Expert Jeffrey Gordon
Agilent Technologies Inc. (NYSE: A) today announced that Dr. Jeffrey Gordon has received an Agilent Thought Leader Award in support of his pioneering research into the mutually beneficial relationship between the human body and the tens of trillions ...
-
Agilent Technologies Presents 2015 Early Career Professor Award to Dr. Mitchell Guttman of Caltech
Agilent Technologies Inc. (NYSE: A) today named Dr. Mitchell Guttman the winner of its 2015 Early Career Professor Award. The award, now in its seventh year, recognizes one early career professor for his or her exceptional, original research ...
-
Seahorse Executive Jay Teich Receives SFRBM CEO Innovator Award
Jay Teich, former Seahorse Bioscience CEO, received the first-ever CEO Innovator Award from the Society for Redox Biology and Medicine (SFRBM). This international award recognizes industry leaders who have transformed the face of scientific research ...
-
Agilent Technologies Completes Acquisition of Seahorse Bioscience, Industry Leader in Tools for Measuring Cell Metabolism
Agilent Technologies Inc. today announced it has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Agilent announced its intent to acquire Seahorse on ...
-
Dako, an Agilent Technologies Company, Announces FDA Approval of New Test for Lung Cancer Patients
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced the U.S. Food and Drug Administration has approved a new test that can identify PD-L1 expression levels on the surface of non-small cell lung ...
-
Agilent Technologies Shares Vision for Precision Genomics at ASHG 2015
Agilent Technologies Inc. (NYSE: A) is sharing its vision for precision medicine this week at the annual meeting of the American Society of Human Genomics. The conference, held in Baltimore, Maryland, is a forum for discussing recent advances in all ...
-
Dako, an Agilent Technologies Company, Announces FDA Approval of New Companion Diagnostic for Lung Cancer
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced the U.S. Food and Drug Administration (FDA) approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small ...
-
Agilent Technologies to Acquire Seahorse Bioscience, Industry Leader in Tools for Measuring Cell Metabolism
Agilent Technologies Inc. (NYSE: A) and Seahorse Bioscience today announced they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism ...
-
Agilent Technologies Presents Thought Leader Award to Renowned Systems Pharmacologist Lawrence Lesko
Agilent Technologies Inc. (NYSE: A) announced today that Dr. Lawrence J. Lesko has received an Agilent Thought Leader Award in support of his research into preclinical toxicological assessments of new medicines. An internationally recognized ...
-
Agilent Technologies Launches Updated Gene Expression Microarrays for Human, Mouse and Rat Models
Agilent Technologies Inc. (NYSE: A) today announced updates to its SurePrint gene expression microarrays for messenger RNA profiling applications for human, mouse and rat models. The updates improve coding and noncoding content, which will provide ...
-
Agilent Technologies Releases New Target-Enrichment Solutions for Disease Research
Agilent Technologies Inc. (NYSE: A) today announced new additions to its market-leading SureSelect target-enrichment product family, which has already enabled researchers to identify more than 50 Mendelian disease-causing genes. The new ...
-
Agilent Technologies Presents Thought Leader Award to Lipidomics Expert Dr. Jules Griffin
Agilent Technologies Inc. (NYSE: A) today announced that Jules Griffin has received an Agilent Thought Leader Award in recognition of his work in lipidomics. This award includes an Agilent 6560 Ion Mobility Q-TOF LC/MS system, which Dr. Griffin and ...
-
Dako, an Agilent Technologies Company, Announces Expanded Collaboration with Amgen Within Companion Diagnostics
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced a new Master Collaboration Agreement with Amgen Inc., a leading biotechnology company. The expanded collaboration will allow both companies to ...
-
Agilent Technologies Receives Innovation Award for Multiple Heart-Cutting Solution
Agilent Technologies Inc. (NYSE: A) today announced that The Analytical Scientist magazine has recognized the Agilent 1290 Infinity II 2D-LC solution with multiple heart-cutting as one of most transformative technologies introduced last year. The ...
-
Agilent Technologies Boosts Productivity of Biopharmaceutical Labs with MassHunter Enhancements
Agilent Technologies Inc. (NYSE: A) today announced new software releases designed to make research and development easier for scientists in the biopharmaceutical field. Enhancements to the company`s industry-leading MassHunter BioConfirm and ...
-
Agilent Technologies Introduces Two Innovative Products to Advance Clinical Cancer Research
Agilent Technologies Inc. (NYSE: A) today launched two new products-the HaloPlexHS target enrichment system and ClearSeq Comprehensive Cancer research panel-designed to improve the speed and accuracy of clinical cancer research. Both products will ...
-
Agilent Technologies Introduces OneSeq to Streamline Cytogenetic Research
Agilent Technologies Inc. (NYSE: A) today introduced OneSeq, the industry`s first all-in-one target enrichment product for next-generation sequencing. OneSeq is designed to detect and analyze copy number variations, loss of heterozygosity, and ...
-
Dako, an Agilent Technologies Company, and Cell Signaling Technology Announce Partnership Within Companion Diagnostics
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology (CST), a worldwide provider of antibodies, today announced that they have entered into a strategic partnership to supply antibodies ...
-
Agilent Technologies Introduces New Column Innovations for Biotherapeutics Development
Agilent Technologies Inc. (NYSE: A) today introduced the AdvanceBio RP-mAb, a reversed-phase column optimized to separate monoclonal antibodies. The AdvanceBio RP-mAb-the latest in a series of products in the AdvanceBio family-is part of Agilent`s ...
-
Agilent Technologies Introduces Focused Exome Kit with Unparalleled Coverage, Speed, Flexibility for Disease Research
Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Focused Exome, a target enrichment solution that enables deep coverage of only those target regions that have been associated with disease. The latest design is 16 Mb in size and ...